David Langsam, Author at Stockhead

Stories by David Langsam

Fliers, flameouts and fakers: what happened in biotechland in 2018

Health & Biotech 21 Dec 2018 David Langsam

Fliers, flameouts and fakers: what happened in biotechland in 2018

You've come a long way baby ... ASX biotech revenue is up 40 per cent over seven years. Picture: Getty

Health & Biotech 5 Sep 2017 David Langsam

Biotechs report $11.7bn revenue and $1.9bn profit

Eureka ... Which biotech returned 394 per cent over ten years? Pic: Getty

Health & Biotech 14 Aug 2017 David Langsam

Biotechs up 80pc over ten years, easily beating the ASX200

StockTake: Alice Queen fuels Fijian gold mission with fresh cash injection

Long Shortz with ClearVue Technologies: Tapping into NZ with Viridian Glass partnership

Long Shortz

StockTake: Anson locks in first of its kind royalty rate for Green River lithium

StockTake

Long Shortz with Future Battery Minerals: Full Miriam minerals acquired for Goldfields drilling

Long Shortz